• 3D Medicines set its board lineup, led by executive director Dr. Gong Zhaolong.
• Non-executive directors: Zhou Feng, Chen Yawen, Zhang Wenhua.
• Independent non-executive directors: Dr. Li Jing, Dr. Lian Dapeng, Liu Xinguang.
• Audit committee chaired by Dr. Lian Dapeng; members include Zhou Feng, Dr. Li Jing.
• Remuneration committee chaired by Liu Xinguang; nomination committee chaired by Dr. Gong Zhaolong.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 3D Medicines Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260807-12277907), on August 07, 2026, and is solely responsible for the information contained therein.